1. Home
  2. WORX vs ARTL Comparison

WORX vs ARTL Comparison

Compare WORX & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WORX
  • ARTL
  • Stock Information
  • Founded
  • WORX N/A
  • ARTL 2011
  • Country
  • WORX United States
  • ARTL United States
  • Employees
  • WORX N/A
  • ARTL N/A
  • Industry
  • WORX Services-Misc. Amusement & Recreation
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • WORX Consumer Discretionary
  • ARTL Health Care
  • Exchange
  • WORX Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • WORX 3.4M
  • ARTL 3.7M
  • IPO Year
  • WORX N/A
  • ARTL N/A
  • Fundamental
  • Price
  • WORX $1.80
  • ARTL $1.21
  • Analyst Decision
  • WORX
  • ARTL Strong Buy
  • Analyst Count
  • WORX 0
  • ARTL 2
  • Target Price
  • WORX N/A
  • ARTL $5.50
  • AVG Volume (30 Days)
  • WORX 57.7K
  • ARTL 28.9K
  • Earning Date
  • WORX 11-14-2024
  • ARTL 11-12-2024
  • Dividend Yield
  • WORX N/A
  • ARTL N/A
  • EPS Growth
  • WORX N/A
  • ARTL N/A
  • EPS
  • WORX N/A
  • ARTL N/A
  • Revenue
  • WORX $3,224,146.00
  • ARTL N/A
  • Revenue This Year
  • WORX N/A
  • ARTL N/A
  • Revenue Next Year
  • WORX N/A
  • ARTL N/A
  • P/E Ratio
  • WORX N/A
  • ARTL N/A
  • Revenue Growth
  • WORX N/A
  • ARTL N/A
  • 52 Week Low
  • WORX $0.75
  • ARTL $0.91
  • 52 Week High
  • WORX $4.44
  • ARTL $1.75
  • Technical
  • Relative Strength Index (RSI)
  • WORX 52.47
  • ARTL 64.07
  • Support Level
  • WORX $1.66
  • ARTL $1.09
  • Resistance Level
  • WORX $1.88
  • ARTL $1.19
  • Average True Range (ATR)
  • WORX 0.18
  • ARTL 0.06
  • MACD
  • WORX -0.00
  • ARTL 0.01
  • Stochastic Oscillator
  • WORX 48.96
  • ARTL 100.00

About WORX SCWorx Corp.

SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing, and commercializing treatments that control endocannabinoid systems. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.

Share on Social Networks: